A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment

Clinical trial NCT01713426 · COMPLETED

Trial details

NCT number: NCT01713426
Sponsor: Astellas Pharma Europe Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-diabetic Painful Peripheral Polyneuropathy Postherpetic Neuralgia (PHN)Peripheral Nerve Injury (PNI)

Start date: 2012-07-11
Primary completion: 2013-09-26
Enrollment: 568

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.